Literature DB >> 28320778

The Epitranscriptome of Noncoding RNAs in Cancer.

Manel Esteller1,2,3, Pier Paolo Pandolfi4.   

Abstract

The activity of RNA is controlled by different types of post-transcriptional modifications, such as the addition of methyl groups and other chemical and structural changes, that have been recently described in human cells by high-throughput sequencing. Herein, we will discuss how the so-called epitranscriptome is disrupted in cancer and what the contribution of its writers, readers, and erasers to the process of cellular transformation is, particularly focusing on the epigenetic modifications of ncRNAs.Significance: Chemical modifications of RNA play a central role in the control of messenger and ncRNA activity and, thus, are tightly regulated in cells. In this review, we provide insight into how these marks are altered in cancer cells and how this knowledge can be translated to the clinical setting. Cancer Discov; 7(4); 359-68. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28320778      PMCID: PMC5997407          DOI: 10.1158/2159-8290.CD-16-1292

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  104 in total

Review 1.  An Adenine Code for DNA: A Second Life for N6-Methyladenine.

Authors:  Holger Heyn; Manel Esteller
Journal:  Cell       Date:  2015-04-30       Impact factor: 41.582

2.  N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.

Authors:  Xiao Wang; Boxuan Simen Zhao; Ian A Roundtree; Zhike Lu; Dali Han; Honghui Ma; Xiaocheng Weng; Kai Chen; Hailing Shi; Chuan He
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

3.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

4.  Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.

Authors:  Andrew Yoon; Guang Peng; Yves Brandenburger; Yves Brandenburg; Ornella Zollo; Wei Xu; Eduardo Rego; Davide Ruggero
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

5.  The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.

Authors:  Michaela Frye; Fiona M Watt
Journal:  Curr Biol       Date:  2006-05-23       Impact factor: 10.834

6.  RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine.

Authors:  Benjamin Delatte; Fei Wang; Long Vo Ngoc; Evelyne Collignon; Elise Bonvin; Rachel Deplus; Emilie Calonne; Bouchra Hassabi; Pascale Putmans; Stephan Awe; Collin Wetzel; Judith Kreher; Romuald Soin; Catherine Creppe; Patrick A Limbach; Cyril Gueydan; Véronique Kruys; Alexander Brehm; Svetlana Minakhina; Matthieu Defrance; Ruth Steward; François Fuks
Journal:  Science       Date:  2016-01-15       Impact factor: 47.728

7.  Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines.

Authors:  Matthias Schaefer; Sabine Hagemann; Katharina Hanna; Frank Lyko
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

8.  Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome.

Authors:  Bastian Linder; Anya V Grozhik; Anthony O Olarerin-George; Cem Meydan; Christopher E Mason; Samie R Jaffrey
Journal:  Nat Methods       Date:  2015-06-29       Impact factor: 28.547

9.  The ribosome assembly factor Nep1 responsible for Bowen-Conradi syndrome is a pseudouridine-N1-specific methyltransferase.

Authors:  Jan Philip Wurm; Britta Meyer; Ute Bahr; Martin Held; Olga Frolow; Peter Kötter; Joachim W Engels; Alexander Heckel; Michael Karas; Karl-Dieter Entian; Jens Wöhnert
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

10.  Long non-coding RNAs as targets for cytosine methylation.

Authors:  Thomas Amort; Marie F Soulière; Alexandra Wille; Xi-Yu Jia; Heidi Fiegl; Hildegard Wörle; Ronald Micura; Alexandra Lusser
Journal:  RNA Biol       Date:  2013-04-01       Impact factor: 4.652

View more
  59 in total

Review 1.  Dynamic RNA Modifications in Gene Expression Regulation.

Authors:  Ian A Roundtree; Molly E Evans; Tao Pan; Chuan He
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

2.  Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.

Authors:  Rosaura Esteve-Puig; Fina Climent; David Piñeyro; Eva Domingo-Domènech; Veronica Davalos; Maite Encuentra; Anna Rea; Nadia Espejo-Herrera; Marta Soler; Miguel Lopez; Vanessa Ortiz-Barahona; Gustavo Tapia; José-Tomás Navarro; Joan Cid; Lourdes Farré; Alberto Villanueva; Isolda Casanova; Ramon Mangues; Pablo Santamarina-Ojeda; Agustín F Fernández; Mario F Fraga; Miguel Angel Piris; Nitzan Kol; Chen Avrahami; Sharon Moshitch-Moshkovitz; Gideon Rechavi; Anna Sureda; Manel Esteller
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

Review 3.  Non-coding RNA networks in cancer.

Authors:  Eleni Anastasiadou; Leni S Jacob; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2017-11-24       Impact factor: 60.716

Review 4.  Epigenetic mechanisms regulating COVID-19 infection.

Authors:  Sarantis Chlamydas; Athanasios G Papavassiliou; Christina Piperi
Journal:  Epigenetics       Date:  2020-07-30       Impact factor: 4.528

5.  RNA modifications and cancer.

Authors:  Phensinee Haruehanroengra; Ya Ying Zheng; Yubin Zhou; Yun Huang; Jia Sheng
Journal:  RNA Biol       Date:  2020-02-07       Impact factor: 4.652

Review 6.  Role of RNA modifications in cancer.

Authors:  Isaia Barbieri; Tony Kouzarides
Journal:  Nat Rev Cancer       Date:  2020-04-16       Impact factor: 60.716

7.  Active Site Breathing of Human Alkbh5 Revealed by Solution NMR and Accelerated Molecular Dynamics.

Authors:  Jeffrey A Purslow; Trang T Nguyen; Timothy K Egner; Rochelle R Dotas; Balabhadra Khatiwada; Vincenzo Venditti
Journal:  Biophys J       Date:  2018-10-11       Impact factor: 4.033

8.  N-terminal fusion of the N-terminal domain of bacterial enzyme I facilitates recombinant expression and purification of the human RNA demethylases FTO and Alkbh5.

Authors:  Balabhadra Khatiwada; Jeffrey A Purslow; Eric S Underbakke; Vincenzo Venditti
Journal:  Protein Expr Purif       Date:  2019-11-15       Impact factor: 1.650

Review 9.  Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer.

Authors:  Andrew W Caliri; Stella Tommasi; Ahmad Besaratinia
Journal:  Mutat Res Rev Mutat Res       Date:  2021-01-11       Impact factor: 5.657

10.  Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine.

Authors:  Balraj Singh; Vanessa N Sarli; Anthony Lucci
Journal:  Oncotarget       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.